EXODIAMOND | From Scientific Vision to Global Bioinnovation

EXODIAMOND represents the convergence of scientific vision, multidisciplinary expertise, and strategic brand development within IMD. Conceived through a forward-looking approach to advanced dermocosmetic innovation, the project brings together scientific research, biological source exploration, technology assessment, and international market insight within a coordinated development framework. From its earliest conceptual foundations, EXODIAMOND has evolved through a systematic process connecting scientific opportunity with product architecture, professional market requirements, and a distinctive global brand identity.

At the scientific core of EXODIAMOND lies EXOTRIO, an integrated bioinnovation platform built around three carefully selected biological sources: Genuine Panax Ginseng (GPG), Genuine Saururaceae Member Houttuynia cordata (GSM), and Genuine Resurrection Plant Rose of Jericho (GRP). Guided by the principle “Where Science Shapes Bioinnovation,” the platform draws upon the evolving scientific understanding of Plant-Derived Extracellular Vesicles (PDEVs) and their potential relevance to advanced cosmetic formulation research. Supported by EXOMEDI's patented production technologies and specialised manufacturing capabilities, this foundation brings together biological source identity, technological integration, formulation development, and product quality within a coherent scientific framework.

The transformation of this scientific platform into a defined dermocosmetic portfolio reflects a coordinated process of product development, formulation architecture, quality assurance, regulatory planning, and professional application design. The EXOTRIO collection encompasses three complementary cosmetic formats: the Professional Clinic Vial system, After Care Serum, and Home Use Cream. Each format forms part of a unified product architecture, supported by considerations of formulation preservation, product consistency, technical documentation, packaging development, and alignment with applicable cosmetic regulatory requirements. Together, these elements establish a structured foundation for international market introduction.

As the brand owner and global commercialisation authority, IMD provides the strategic direction behind EXODIAMOND, coordinating its international project management and commercialisation activities from London. In collaboration with EXOMEDI in South Korea as its manufacturing partner, IMD brings together scientific innovation, regulatory coordination, brand positioning, professional engagement, and international market development within an integrated strategic framework. Guided by the international vision “From London to the World” and the brand philosophy “Beyond Expectation,” EXODIAMOND reflects a long-term commitment to scientific advancement, responsible innovation, and sustainable global brand development.